Tanikawa C - Search Results

1

Novel Risk Loci Identified in a Genome-Wide Association Study of Urolithiasis in a Japanese Population.

Tanikawa C, Kamatani Y, Terao C, Usami M, Takahashi A, Momozawa Y, Suzuki K, Ogishima S, Shimizu A, Satoh M, Matsuo K, Mikami H, Naito M, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Kohri K, Yu ASL, Yasui T, Murakami Y, Kubo M, Matsuda K. Tanikawa C, et al. J Am Soc Nephrol. 2019 May;30(5):855-864. doi: 10.1681/ASN.2018090942. Epub 2019 Apr 11. J Am Soc Nephrol. 2019. PMID: 30975718 Free PMC article.

2

Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.

Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y, Arakawa H. Shiraishi K, et al. Among authors: tanikawa c. Cancer Res. 2000 Jul 15;60(14):3722-6. Cancer Res. 2000. PMID: 10919640

3

p53RDL1 regulates p53-dependent apoptosis.

Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. Tanikawa C, et al. Nat Cell Biol. 2003 Mar;5(3):216-23. doi: 10.1038/ncb943. Nat Cell Biol. 2003. PMID: 12598906

4

CDC20, a potential cancer therapeutic target, is negatively regulated by p53.

Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. Kidokoro T, et al. Among authors: tanikawa c. Oncogene. 2008 Mar 6;27(11):1562-71. doi: 10.1038/sj.onc.1210799. Epub 2007 Sep 17. Oncogene. 2008. PMID: 17873905

5

XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway.

Tanikawa C, Furukawa Y, Yoshida N, Arakawa H, Nakamura Y, Matsuda K. Tanikawa C, et al. Oncogene. 2009 Aug 27;28(34):3081-92. doi: 10.1038/onc.2009.154. Epub 2009 Jun 22. Oncogene. 2009. PMID: 19543321

6

Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.

Tanikawa C, Ueda K, Nakagawa H, Yoshida N, Nakamura Y, Matsuda K. Tanikawa C, et al. Cancer Res. 2009 Nov 15;69(22):8761-9. doi: 10.1158/0008-5472.CAN-09-2280. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843866

7

Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway.

Tanikawa C, Ri C, Kumar V, Nakamura Y, Matsuda K. Tanikawa C, et al. Mol Cancer Res. 2010 Jun;8(6):855-63. doi: 10.1158/1541-7786.MCR-09-0484. Epub 2010 May 25. Mol Cancer Res. 2010. PMID: 20501644

8

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.

Cui R, Okada Y, Jang SG, Ku JL, Park JG, Kamatani Y, Hosono N, Tsunoda T, Kumar V, Tanikawa C, Kamatani N, Yamada R, Kubo M, Nakamura Y, Matsuda K. Cui R, et al. Among authors: tanikawa c. Gut. 2011 Jun;60(6):799-805. doi: 10.1136/gut.2010.215947. Epub 2011 Jan 17. Gut. 2011. PMID: 21242260 Free PMC article.

9

Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility.

Kumar V, Matsuo K, Takahashi A, Hosono N, Tsunoda T, Kamatani N, Kong SY, Nakagawa H, Cui R, Tanikawa C, Seto M, Morishima Y, Kubo M, Nakamura Y, Matsuda K. Kumar V, et al. Among authors: tanikawa c. J Hum Genet. 2011 Jun;56(6):436-9. doi: 10.1038/jhg.2011.35. Epub 2011 Apr 7. J Hum Genet. 2011. PMID: 21471979

10

Regulation of histone modification and chromatin structure by the p53-PADI4 pathway.

Tanikawa C, Espinosa M, Suzuki A, Masuda K, Yamamoto K, Tsuchiya E, Ueda K, Daigo Y, Nakamura Y, Matsuda K. Tanikawa C, et al. Nat Commun. 2012 Feb 14;3:676. doi: 10.1038/ncomms1676. Nat Commun. 2012. PMID: 22334079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page